Published

Company on brink takes psilocybin to trial for fragile X syndrome

No abstract availability was recorded for this entry.

Open source BibTeX RIS

Bibliographic context

Journal: The Transmitter
Date: 2023-01-01
Source: OpenAlex
DOI: 10.53053/mkkk7368
PubMed: Unavailable

Authors

Peter Hess

Watch author

Derived topics and classifications

psilocybin General Other

Citation graph

0 referenced DOIs found in stored source metadata. 1 indexed paper cite this DOI.

Open citation network

Indexed papers citing this DOI

Company on brink takes psilocybin to trial for fragile X syndrome2023-01-01

Related papers

Session on Psychedelics Sure to Be EnlighteningPsychiatric News · 2021-03-01 The psychedelic renaissance: psilocybin, a breakthrough for treatment resistant depression?Exploration of neuroscience · 2025-08-07 Esse quam Videre: Critical Reflections on the Use of Psilocybin as an Adjuvant in Psychedelic-Assisted PsychotherapyPolymatheia. · 2025-02-15